Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Choudhuri G, Chaudhari S, Pawar D, et al. Etiological patterns, liver fibrosis stages and prescribing patterns of hepato-protective agents in Indian patients with chronic liver disease. J Assoc Physicians India. 2018;66:58–63.
2. Jhajharia A, Soni A, Pokharna R, et al. Spectrum of chronic liver disease admitted to a medical college hospital in northern India: is there cause for concern? Indian J Gastroenterol. 2014;33:480–1. https://doi.org/10.1007/s12664-014-0465-z.
3. Mukherjee PS, Vishnubhatla S, Amarapurkar DN, et al. Etiology and mode of presentation of chronic liver diseases in India: a multi centric study. PLoS One. 2017;12:e0187033. https://doi.org/10.1371/journal.pone.0187033.
4. Manthey J, Shield KD, Rylett M, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393:2493–502. https://doi.org/10.1016/S0140-6736(18)32744-2.
5. Balhara YPS, Chattopadhyay A, Sarkar S. The, “Hidden Story” about change in alcohol use in India over the past two decades: insights from a secondary analysis of data from the National Family Health Survey. Indian J Psychol Med. 2022;44:234–8. https://doi.org/10.1177/02537176211033004.